4-MeO-DMT

Chemical compound From Wikipedia, the free encyclopedia

4-MeO-DMT, or 4-methoxy-DMT, also known as 4-methoxy-N,N-dimethyltryptamine or as O-methylpsilocin (PSOM), is a serotonin receptor modulator and possible psychedelic drug of the tryptamine and 4-hydroxytryptamine families.[1][2][3][4][5] It is the O-methylated analogue of psilocin (4-HO-DMT) and a positional isomer of 5-MeO-DMT.[1][5]

Other names4-OMe-DMT; 4-Methoxy-DMT; 4-Methoxy-N,N-dimethyltryptamine; O-Methylpsilocin; PSOM
CAS Number
Quick facts Clinical data, Other names ...
4-MeO-DMT
Clinical data
Other names4-OMe-DMT; 4-Methoxy-DMT; 4-Methoxy-N,N-dimethyltryptamine; O-Methylpsilocin; PSOM
Drug classSerotonin receptor modulator; Serotonergic psychedelic; Hallucinogen
Identifiers
  • 2-(4-Methoxy-1H-indol-3-yl)-N,N-dimethylethanamine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H18N2O
Molar mass218.300 g·mol−1
3D model (JSmol)
  • CN(C)CCC1=CNC2=CC=CC(OC)=C21
  • InChI=1S/C13H18N2O/c1-15(2)8-7-10-9-14-11-5-4-6-12(16-3)13(10)11/h4-6,9,14H,7-8H2,1-3H3 checkY
  • Key:HFYHBTWTJDAYGW-UHFFFAOYSA-N checkY
  (verify)
Close

Use and effects

According to Alexander Shulgin in his book TiHKAL (Tryptamines I Have Known and Loved), 4-MeO-DMT is not known to have been tested in humans.[6] However, the N,N-diethyl analogue 4-MeO-DET has been tested in humans and was found to be completely inactive at doses of up to 30 mg orally or smoked.[6]

Interactions

Pharmacology

Pharmacodynamics

More information Target, Affinity (Ki, nM) ...
4-MeO-DMT activities
TargetAffinity (Ki, nM)
5-HT1A235
5-HT2A68–1,300
5-HT2C340
Notes: The smaller the value, the more avidly the drug interacts with the site. Sources:[7][8]
Close

4-MeO-DMT has shown high affinity for several serotonin receptors, including the serotonin 5-HT1A receptor (Ki = 235 nM), the serotonin 5-HT2A receptor (Ki = 68–1,300 nM), and the serotonin 5-HT2C receptor (Ki = 340 nM).[7][8] Compared to 5-MeO-DMT, 4-MeO-DMT had similar affinity for the serotonin 5-HT2A receptor, but showed much lower affinity (21-fold) for the serotonin 5-HT1A receptor.[7][8] The drug shows pronounced biased agonism at the serotonin 5-HT2C receptor.[9]

4-MeO-DMT produces serotonergic psychedelic-like effects in animals, including rodents and monkeys.[1][2][3][4][5] It has been found to disrupt object size discrimination performance in monkeys, suggesting that it may have psychedelic effects in humans.[1][10] However, whereas 5-MeO-DMT has greater potency than bufotenin (5-HO-DMT), 4-MeO-DMT has lower potency than psilocybin (4-PO-DMT).[1] This may be due to the fact that the lipophilicity of psilocin is not importantly enhanced by O-methylation, in contrast to the case of bufotenin, which has associated limitations in terms of blood–brain barrier permeability.[1] Besides psilocin/psilocybin, 4-MeO-DMT is also less potent than 5-MeO-DMT.[2]

4-MeO-DMT fully substituted for DOM in rodent drug discrimination tests, with an ED50Tooltip median effective dose of about 3.53 mg/kg and about 3-fold lower potency than 5-MeO-DMT.[11] 4-MeO-DMT also substituted for 5-MeO-DMT in rodent drug discrimination tests, with an ED50 of 3.47 μmol/kg and about 2.7-fold lower potency than 5-MeO-DMT.[12]

Chemistry

Analogues

Analogues of 4-MeO-DMT include dimethyltryptamine (DMT), 4-methoxytryptamine (4-MT or 4-MeO-T), psilocin (4-HO-DMT), 4-AcO-DMT (psilacetin), 4-MeO-DET, 4-MeO-DiPT, 4-MeO-MiPT, 4-methyl-DMT, 5-MeO-DMT, 6-MeO-DMT, and 7-MeO-DMT, among others.[6]

History

4-MeO-DMT was first described in the scientific literature by at least 1968.[1][13]

Society and culture

Canada

4-MeO-DMT is not a controlled substance in Canada.[14]

United States

In the United States, 4-MeO-DMT is a Schedule I controlled substance as it is a positional isomer of 5-MeO-DMT.[15][16]

See also

References

Related Articles

Wikiwand AI